The European Fee stated on Sunday it had reached an settlement with BioNTech and Pfizer for an additional 20 million doses of their COVID-19 vaccine to be delivered to EU member states within the first quarter of 2022.
These doses come on prime of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the whole variety of deliveries within the first quarter to 215 million, a fee assertion stated.
The fee and member states have additionally exercised an choice to order greater than 200 million BioNTech-Pfizer COVID-19 doses tailored for the Omicron variant and count on supply from the second quarter of 2022.
These doses would convey the whole variety of deliveries by BioNTech-Pfizer to 650 million doses throughout 2022, the fee assertion stated.
Governments throughout Europe are struggling to curb a pointy rise in COVID-19 infections brought on by the speedy unfold of the newly found Omicron coronavirus variant.
On Dec. 16, the European Fee had stated that it has reached an settlement with Moderna to hurry deliveries of the U.S. firm’s COVID-19 vaccine to Germany and different European Union member states.
(Reuters)